Albus is thrilled to announce that we were awarded UCB’s Jury Choice Award at the Demo Day hosted in Brussels at the start of 2024.

The investment of leading pharma companies into programs such as Digital Health Incubator highlights the industry’s need for better tools to enable seamless data collection in clinical trials. We are proud to lead the way in this direction and honoured to be recognised for our product. Monitoring nocturnal (nighttime) parameters with clinical accuracy can provide unprecedented insights into the health status of patients with chronic diseases – we are committed to unlocking this potential from a third of our lives, using a contactless passive device that does not pose any patient burden.